Food and Drug Administration

Anesthetic and Life Support Drugs Advisory Committee

January 31, 2002


Ensuring Proper Use and Curbing Abuse of Opiods: An Industry perspective, J David Haddox, DDS, MD, Purdue Pharma, LP   ppt   htm

Findings from the Drug Abuse Warning Network, Narcotic Analgesics, Judy K ball, PhD, MPA, Office of Applied Studies, Substance Abuse and Mental Health Services Administration   ppt   htm

Abuse Liability and Drug Scheduling: The Role of the FDA, Deborah Leiderman, MD, FDA   ppt  htm

An Epidemiologic Overview of Prescription Drug Misuse, Howard D Chilcoat, Tracy Dusablon, Department of Mental Hygiene, John Hopkins University, School of Hygiene and Public Health   ppt   htm

Substance Abuse Issues in Chronic Pain Management, Steven D Passik, PhD, Oncology Symptom Control and Research, Community Cancer Care, Inc.   ppt   htm

Prescription Drug Abuse, Sharon Hertz, MD, FDA   ppt   htm